ArticleJournal of thoracic disease2011
Early enteral infusion of traditional Chinese medicine preparation can effectively promote the recovery of gastrointestinal function after esophageal cancer surgery.
Article in Journal of thoracic disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 7 citations in OpenAlex.
- Early initiation of oral feeding following upper gastrointestinal tumor surgery: a randomized controlled trial.Surgery today · 2015Trial
- Longitudinal analysis of postoperative symptom clusters in patients undergoing esophageal cancer surgery.Journal of thoracic disease · 2025Article
- Immunomodulatory Effects of L-Arginine-Modified Silkworm Pupae Protein Enteral Nutrition on Murine Intestinal Morphology and Immunity.International journal of molecular sciences · 2025Article
- Can Chinese herbal medicine offer feasible solutions for newly diagnosed esophageal cancer patients with malnutrition? a multi-institutional real-world study.Frontiers in pharmacology · 2024Article
- The effectiveness of telephone and internet-based supportive care for patients with esophageal cancer on enhanced recovery after surgery in China: A randomized controlled trial.Asia-Pacific journal of oncology nursing · 2022Article
- The association between mortality and use of Chinese herbal medicine among incident stage IV esophageal cancer patients: A retrospective cohort study with core herbs exploration.Frontiers in pharmacology · 2022Article
- Herbal Medicine, Gut Microbiota, and COVID-19.Frontiers in pharmacology · 2021Review
- Early Oral Feeding After Surgery for Upper Gastrointestinal Malignancies: A Prospective Cohort Study.Oman medical journal · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the effectiveness and safety of the enteral infusion of traditional Chinese medicine (TCM) preparation in promoting the recovery of gastrointestinal function in patients who have received surgery for esophageal cancer.
methodsOf patients who received surgeries for their esophageal cancers in the Sun Yat-Sen University Cancer Center from October 2009 to July 2011, 100 patients were enrolled and randomly divided into TCM group (n=50) and control group (n=50): in the TCM group, 200 ml home-made TCM preparation was administered via the enteral feeding tube after the enteral nutrition was provided once daily one day after surgery. In the control group, 200 ml normal saline was administered via the enteral feeding tube after the enteral nutrition was provided one day after surgery. Both groups were infused until the gastrointestinal function returned normal. The time to first audible bowel sounds, bowel sound recovery time, time to first flatus, time to first stool, and abdominal symptom score were compared between these two groups.
resultsThe time to first audible bowel sounds, bowel sound recovery time, time to first flatus, and time to first stool were 34.68±6.92 h, 60.56±9.188 h, 58.52±8.986 h, and 90.38±15.379 h in the TCM group and 43.04±8.214 h, 68.72±10.180 h, 64.64±10.198 h, and 99.28±15.456 h in the control group (p=0.002, p=0.005, p<0.001, p<0.001, respectively).
conclusionsEarly enteral injection of TCM preparation via the enteral feeding tube can effectively and safely promote the recovery of gastrointestinal function after esophageal cancer surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.